High resolution NMR for screening ligand/protein binding

M J Shapiro1, J R Wareing

  • 1Department of Analytics, Preclinical Research, Novartis Institute for Biomedical Research, Summit, NJ 07901, USA. michael.shapiro@pharma.novartis.com

Current Opinion in Drug Discovery & Development
|August 4, 2009
PubMed